ImmunoGen Teams Up With Huadong Medicine to Develop Mirvetuximab in China
News
ImmunoGen has announced a collaboration with Hangzhou Zhongmei Huadong Pharmaceutical Co, a subsidiary of Huadong Medicine, to develop and commercialize the ... Read more